Proniosomes as a drug carrier for transdermal delivery of ketorolac

被引:178
作者
Alsarra, IA [1 ]
Bosela, AA [1 ]
Ahmed, SM [1 ]
Mahrous, GM [1 ]
机构
[1] King Saud Univ, Coll Pharm, Dept Pharmaceut, Riyadh 11451, Saudi Arabia
关键词
niosomes; promosomes; ketorolac; transdermal delivery; permeation;
D O I
10.1016/j.ejpb.2004.09.006
中图分类号
R9 [药学];
学科分类号
1007 [药学];
摘要
Niosomes are nonionic surfactant vesicles that have potential applications in the delivery of hydrophobic and hydrophilic drugs. Permeation of a potent nonsteroidal anti-inflammatory, ketorolac, across excised rabbit skin from various promosome gel formulations was investigated using Franz diffusion cells. Each of the prepared proniosomes significantly improved drug permeation and reduced the lag time (P < 0.05). Proniosomes prepared with Span 60 provided a higher ketorolac flux across the skin than did those prepared with Tween 20 (7- and 4-fold the control, respectively). A change in the cholesterol content did not affect the efficiency of the proniosomes, and the reduction in the lecithin content did not significantly decrease the flux (P > 0.05). The encapsulation efficiency and size of niosomal vesicles formed by promosome hydration were also characterized by specific high performance liquid chromatography method and scanning electron microscopy. Each of the prepared niosomes achieved about 99% drug encapsulation. Vesicle size was markedly dependent on the composition of the proniosomal formulations. Proniosomes may be a promising carrier for ketorolac and other drugs, especially due to their simple production and facile up. (c) 2004 Elsevier B.V. All rights reserved.
引用
收藏
页码:485 / 490
页数:6
相关论文
共 26 条
[1]
THE PREPARATION AND PROPERTIES OF NIOSOMES NON-IONIC SURFACTANT VESICLES [J].
BAILLIE, AJ ;
FLORENCE, AT ;
HUME, LR ;
MUIRHEAD, GT ;
ROGERSON, A .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 1985, 37 (12) :863-868
[2]
Barber R., 1993, PILGRIMAGES, P1
[4]
Maltodextrin-based proniosomes [J].
Blazek-Welsh, AI ;
Rhodes, DG .
AAPS PHARMSCI, 2001, 3 (01) :art. no.-1
[5]
ANTHRACYCLINE ANTIBIOTICS IN CANCER-THERAPY - FOCUS ON DRUG-RESISTANCE [J].
BOOSER, DJ ;
HORTOBAGYI, GN .
DRUGS, 1994, 47 (02) :223-258
[6]
LIPOSOMES AND NANOPARTICLES IN THE TREATMENT OF INTRACELLULAR BACTERIAL-INFECTIONS [J].
COUVREUR, P ;
FATTAL, E ;
ANDREMONT, A .
PHARMACEUTICAL RESEARCH, 1991, 8 (09) :1079-1086
[7]
In vitro and in vivo evaluations of the efficacy and safety of skin permeation enhancers using flurbiprofen as a model drug [J].
Fang, JY ;
Hwang, TL ;
Fang, CL ;
Chiu, HC .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2003, 255 (1-2) :153-166
[8]
In vitro skin permeation of estradiol from various proniosome formulations [J].
Fang, JY ;
Yu, SY ;
Wu, PC ;
Huang, YB ;
Tsai, YH .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2001, 215 (1-2) :91-99
[9]
Lipophilic drug derivatives in liposomes [J].
Gulati, M ;
Grover, M ;
Singh, S ;
Singh, M .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1998, 165 (02) :129-168
[10]
Proniosomes: A novel drug carrier preparation [J].
Hu, CJ ;
Rhodes, DG .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1999, 185 (01) :23-35